| | Publication Year | Title | Author(s) |
| 1 | Feb-2024 | Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3. | Thilakasiri, Pathum; O'Keefe, Ryan N; To, Sarah Q; Chisanga, David; Eissmann, Moritz F ; Carli, Annalisa LE; Duscio, Belinda; Baloyan, David; Dmello, Rhynelle S; Williams, David S ; Mariadason, John M ; Poh, Ashleigh R; Pal, Bhupinder; Kile, Benjamin T; Vissers, Joseph Ha; Harvey, Kieran F; Buchert, Michael ; Shi, Wei; Ernst, Matthias ; Chand, Ashwini L |
| 2 | 28-Oct-2023 | A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development. | O'Keefe, Ryan N; Carli, Annalisa L E; Baloyan, David; Chisanga, David; Shi, Wei; Afshar-Sterle, Shoukat ; Eissmann, Moritz F ; Poh, Ashleigh R; Pal, Bhupinder; Seillet, Cyril; Locksley, Richard M; Ernst, Matthias ; Buchert, Michael |
| 3 | 7-Oct-2023 | A Mouse Model for the Rapid and Binomial Assessment of Putative WNT/β-Catenin Signalling Inhibitors. | Tse, Janson; O'Keefe, Ryan; Rigopolous, Angela; Carli, Annalisa L E; Waaler, Jo; Krauss, Stefan; Ernst, Matthias ; Buchert, Michael |
| 4 | 18-Jul-2023 | Deep learning exploration of single-cell and spatially resolved cancer transcriptomics to unravel tumour heterogeneity. | Halawani, Raid; Buchert, Michael ; Chen, Yi-Ping Phoebe |
| 5 | 22-Mar-2023 | Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis. | Carli, Annalisa L E; Hardy, Joshua M; Hoblos, Hanadi; Ernst, Matthias ; Lucet, Isabelle S; Buchert, Michael |
| 6 | Feb-2022 | Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC. | Faux, Maree C; Weinstock, Janet; Gogos, Sophia; Prato, Emma; Azimpour, Alexander I; O'Keefe, Ryan; Cathcart-King, Yasmin; Garnham, Alexandra L; Ernst, Matthias ; Preaudet, Adele; Christie, Michael; Putoczki, Tracy L; Buchert, Michael ; Burgess, Antony W |